Thursday, August 18, 2022

Physical activity affects boys and girls differently

Being physically active has major health benefits. But physical activity affects boys and girls differently

Peer-Reviewed Publication

NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY

Being physically active has major health benefits. But the physical activity affects boys and girls differently. New research has examined the relationship between body fat and physical activity in children.

“We looked at the connection between objectively measured physical activity and the proportion of body fat in girls and boys,” says Silje Steinsbekk, a professor at NTNU’s (the Norwegian University of Science and Technology) Department of Psychology.

The researchers measured participants’ body composition rather than their weight and height. They posed such questions as:

Does increased physical activity lead to a lower percentage of body fat over time? Or is it perhaps the other way around, that people who gain more body fat over time become less physically active?

Body fat and physical activity in girls are unrelated

The researchers examined the children every two years from the age of 6 until they were 14 years old. They found that the level of activity affects the sexes differently.

“In girls, we found no connection between their physical activity and amount of body fat. Increased physical activity didn’t lead to less body fat in the girls, and body fat had no effect on changes in their physical activity,” says Tonje Zahl-Thanem, a former research fellow and first author of the article.

But for boys, it's different. The amount of body fat influences their physical activity.

More body fat in boys results in less physical activity

“Increased body fat in boys led to less physical activity two years later, when they were 8, 10 and 12 years old,” says Zahl-Thanem.

With one exception, increased physical activity had no effect on changes in body fat.

“We found that boys who are more physically active when they’re 12 years old have a lower proportion of body fat when they’re 14. This wasn’t the case at an earlier developmental stage,” Steinsbekk says.

Several possible reasons for differences between the sexes

The study did not investigate the reasons for these differences, but the researchers point out that large bodies are heavier and require more exertion when exercising, which may explain why boys whose body fat increases become less active over time. But why isn’t this the case for girls?

“Here we can only speculate, but boys are generally more physically active than girls, so when boys reduce their activity level, the physical impact is greater,” Steinsbekk says.

We also know that children with large bodies are less satisfied with their bodies, and body dissatisfaction is associated with less physical activity in boys, but not in girls.

“Boys’ physical activity is probably even more competitively oriented than girls', and more body fat makes it more difficult to succeed. Both of these conditions can help explain why increased body fat leads to less physical activity in boys, but not girls,” says Lars Wichstrøm, a professor in NTNU’s Department of Psychology and also co-author of the study.

It could also be that girls are more likely to maintain physical activity when their proportion of body fat increases, because more attention is paid to girls' bodies and appearance.

Body fat affects sedentary activity in boys

The researchers also examined the link between inactivity or a sedentary lifestyle and body fat. In the same way that they objectively measured physical activity, they also measured how long the participants were sedentary during the day.

“The results show that boys who had an increase in the proportion of body fat had a corresponding increase in sedentary activity two years later. This carried through all the age groups studied, from the age of 6 through age 14.

In other words, boys whose proportion of body fat increases become more sedentary.

For the girls, however, there was no link here either. The percentage of body fat did not affect their level of inactivity over time, and they did not become less active by gaining more body fat.

“In sum, we found a link between physical activity, sedentary lifestyle and fat percentage in boys, but not in girls,” Steinsbekk says.

Trondheim Early Secure Study

The researchers used figures from the Trondheim Early Secure Study (TESS). They followed almost 1000 children at two-year intervals from when they were 4 years old. The participants are now 18 years old, and the eighth survey is underway.

In this study, the research group used data at five different times, when the participants were 6, 8, 10, 12 and 14 years old. The Trondheim Early Secure Study has provided data for a number of studies on children's development and health. 

References:

Zahl-Thanem T, Wichstrøm L, Steinsbekk S. Relations between physical activity, sedentary time, and body fat from childhood to adolescence: Do they differ by sex? Int J Obes (Lond). 2022 Jun 3. doi: 10.1038/s41366-022-01156-6. Epub ahead of print. PMID: 35662270.  DOI: 10.1038/s41366-022-01156-6

Zahl-Thanem, T., Wichstrøm, L. & Steinsbekk, S. Relations between physical activity, sedentary time, and body fat from childhood to adolescence: Do they differ by sex?. Int J Obes (2022). https://doi.org/10.1038/s41366-022-01156-6

 

Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity

JAMA Dermatol. Published online August 3, 2022. doi:10.1001/jamadermatol.2022.2426

Psoriasis is a chronic inflammatory skin condition frequently managed by dermatologists. Dermatologists have an obligation to provide each patient with psoriasis with adequate time to address their concerns and develop strong communication and trust. Ineffective physician-patient communication can mean poor treatment adherence, comprehension, satisfaction, and outcomes for the patient.1 It is unclear whether differences exist in the amount of time a dermatologist spends with a patient with psoriasis based on race or ethnicity. We aimed to evaluate the association between a patient’s race and ethnicity and time spent with a dermatologist for psoriasis treatment.

Methods

We performed a cross-sectional study of data from the National Ambulatory Medical Care Survey from 2010 through 2016.2 Data were analyzed January 3 to April 24, 2022. We conducted multivariable linear regression analyses adjusted for age, sex, type of visit (follow-up or new patient), visit complexity based on the number of reasons for visit, insurance status, psoriasis severity on the basis of systemic psoriasis treatment or phototherapy, and complex topical regimen (3 or more topical agents) to evaluate the association between patient race and ethnicity and visit duration for psoriasis treatment with a dermatologist. Race and ethnicity were self-reported by patients. The eMethods in the Supplement provides further details. This study was categorized as exempt by the University of Southern California Institutional Review Board, and the requirement for informed consent was waived because only deidentified data were used. We followed the STROBE reporting guideline. Statistical tests were 2-tailed, and a 2-sided P < .05 was considered statistically significant.

Results

A weighted estimate of 4 201 745 (95% CI, 3 688 629-4 714 862) patient visits for psoriasis was identified. Of the tabulated demographic characteristics, a significant difference existed in age (37.2 [95% CI, 32.0-42.4] years for Asian patients vs 44.7 [95% CI, 33.4-56.0] years for Hispanic patients vs 33.3 [95% CI, 16.9-49.7] years for Black patients vs 54.8 [95% CI, 51.6-58.0] years for White patients; P = .001) and complex topical regimen (11.8% among Asian patients vs 1.5% among Black patients vs 1.1% among White patients; P = .03) among the groups (Table 1). Mean duration of visits was 9.2 (95% CI, 4.4-14.1) minutes with Asian patients, 15.7 (95% CI, 14.2-17.3) minutes with Hispanic or Latino patients, 20.7 (95% CI, 14.5-26.9) minutes with non-Hispanic Black patients, and 15.4 (95% CI, 13.5-17.3) minutes with non-Hispanic White patients. Visits with Asian patients had a 39.9% shorter mean duration compared with visits with White patients (β coefficient, −5.747 [95% CI, −11.026 to −0.469]; P = .03) and a 40.6% shorter mean duration compared with visits with non-Asian patients as a single group (β coefficient, −5.908 [95% CI, −11.147 to −0.669]; P = .03) (Table 2).

Discussion

Results of the present study suggest that Asian patients with psoriasis receive significantly less face-to-face time with a dermatologist compared with patients of other races and ethnicities. This study supports the results of previous studies in which Asian patients were found to be less likely to receive counseling from physicians compared with White patients.3,4 Paradoxically, Asian individuals tend to present with more severe psoriasis compared with individuals of other races and ethnicities.5

The etiology of these differences is unclear. It is possible that factors, such as unconscious bias, cultural differences in communication, or residual confounding may be responsible for the observed findings.3,6 Further research is needed to understand the underlying factors responsible for the differences observed in this study.

This study has limitations. Visit duration was self-reported by the physician or their staff and had been studied in other fields; formal validation studies are pending. Missing data on race and ethnicity were imputed using a sequential regression method.2 It is possible that those patients who did not report race and ethnicity may have different characteristics affecting visit duration vs those who did report this information.

Dermatologists spend less time with Asian patients with psoriasis compared with patients of other races and ethnicities. Dermatologists need to allow sufficient time to develop strong physician-patient communication regardless of patient background.

Back to top
Article Information

Accepted for Publication: May 6, 2022.

Published Online: August 3, 2022. doi:10.1001/jamadermatol.2022.2426

Corresponding Author: April W. Armstrong, MD, MPH, Department of Dermatology, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, KAM 510, MC 9034, Los Angeles, CA 90089 (armstrongpublication@gmail.com).

Author Contributions: Dr Wu had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: All authors.

Acquisition, analysis, or interpretation of data: Wu.

Drafting of the manuscript: All authors.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Wu.

Administrative, technical, or material support: All authors.

Supervision: Armstrong.

Conflict of Interest Disclosures: Dr Armstrong reported receiving personal fees from AbbVie and Regeneron for research funding and serving as a scientific adviser and speaker; Bristol Myers Squibb, Dermavant, Dermira, Eli Lilly & Co., Janssen, Novartis, and UCB Pharma for research funding and serving as a scientific adviser; Modernizing Medicine Ortho Dermatologics, Sanofi Genzyme, Sun Pharma, Pfizer, Almirall, Arcutis Biotherapeutics, ASLAN Pharmaceuticals, Beiersdorf, EPI Health, Incyte, and Nimbus Therapeutics for serving as a scientific adviser; and Boehringer Ingelheim and Parexel for serving as a Data Safety Monitoring Board member outside the submitted work. No other disclosures were reported.

Disclaimer: Dr Armstrong is on the Editorial Board of JAMA Dermatology, but she was not involved in any of the decisions regarding review of the manuscript or its acceptance.

References
1.
Stewart  MA.  Effective physician-patient communication and health outcomes: a review.   CMAJ. 1995;152(9):1423-1433.PubMedGoogle Scholar
2.
Ambulatory health care data: about the ambulatory health care surveys. Centers for Disease Control and Prevention National Center for Health Statistics. Updated December 30, 2021. Accessed January 30, 2019. https://www.cdc.gov/nchs/ahcd/about_ahcd.htm
3.
Ngo-Metzger  Q, Legedza  AT, Phillips  RS.  Asian Americans’ reports of their health care experiences: results of a national survey.   J Gen Intern Med. 2004;19(2):111-119. doi:10.1111/j.1525-1497.2004.30143.xPubMedGoogle ScholarCrossref
4.
Murray-García  JL, Selby  JV, Schmittdiel  J, Grumbach  K, Quesenberry  CP  Jr.  Racial and ethnic differences in a patient survey: patients’ values, ratings, and reports regarding physician primary care performance in a large health maintenance organization.   Med Care. 2000;38(3):300-310. doi:10.1097/00005650-200003000-00007PubMedGoogle ScholarCrossref
5.
Shah  SK, Arthur  A, Yang  YC, Stevens  S, Alexis  AF.  A retrospective study to investigate racial and ethnic variations in the treatment of psoriasis with etanercept.   J Drugs Dermatol. 2011;10(8):866-872.PubMedGoogle Scholar
6.
Saposnik  G, Redelmeier  D, Ruff  CC, Tobler  PN.  Cognitive biases associated with medical decisions: a systematic review.   BMC Med Inform Decis Mak. 2016;16(1):138. doi:10.1186/s12911-016-0377-1PubMedGoogle ScholarCrossref

Wednesday, August 17, 2022

Augmented reality could be the future of paper books, according to new research 

Peer-Reviewed Publication

UNIVERSITY OF SURREY

Augmented reality books 

IMAGE: NEXT GENERATION PAPER BOOK EXAMPLE view more 

CREDIT: COURTESY OF ADVANCED TECHNOLOGY INSTITUTE

 

Augmented reality might allow printed books to make a comeback against the e-book trend, according to researchers from the University of Surrey.  

Surrey has introduced the third generation (3G) version of its Next Generation Paper (NGP) project, allowing the reader to consume information on the printed paper and screen side by side.  

Dr Radu Sporea, Senior lecturer at the Advanced Technology Institute (ATI), comments: 

“The way we consume literature has changed over time with so many more options than just paper books. Multiple electronic solutions currently exist, including e-readers and smart devices, but no hybrid solution which is sustainable on a commercial scale.  

“Augmented books, or a-books, can be the future of many book genres, from travel and tourism to education. This technology exists to assist the reader in a deeper understanding of the written topic and get more through digital means without ruining the experience of reading a paper book.” 

Power efficiency and pre-printed conductive paper are some of the new features which allow Surrey’s augmented books to now be manufactured on a semi-industrial scale. With no wiring visible to the reader, Surrey’s augmented reality books allow users to trigger digital content with a simple gesture (such as a swipe of a finger or turn of a page), which will then be displayed on a nearby device.  

George Bairaktaris, Postgraduate researcher at the University of Surrey and part of the Next Generation Paper project team, said: 

“The original research was carried out to enrich travel experiences by creating augmented travel guides. This upgraded 3G model allows for the possibility of using augmented books for different areas such as education. In addition, the new model disturbs the reader less by automatically recognising the open page and triggering the multimedia content.” 

“What started as an augmented book project, evolved further into scalable user interfaces. The techniques and knowledge from the project led us into exploring organic materials and printing techniques to fabricate scalable sensors for interfaces beyond the a-book”.  

More information on the upgraded 3G augmented reality book will appear in IEEE Pervasive Computing magazine, which can be found here

Ends 

Notes to Editors

  • Research on the 2G ‘augmented reality-book’ was published in e-Review of Tourism Research in 2019 by Dr Emily Corrigan-Kavanagh 

  • More information on this research can be found here : http://teamsporea.info/research/user_interfaces/ 

  • Dr Radu Sporea is available for interview upon request 

  • Contact the University’s press office via mediarelations@surrey.ac.uk 

 

More women turning to medical cannabis for relief of menopause symptoms

New study finds that a growing number of primarily perimenopausal women are using medical cannabis to treat menopause symptoms such as sleep disturbance and mood/anxiety

Peer-Reviewed Publication

THE NORTH AMERICAN MENOPAUSE SOCIETY (NAMS)

CLEVELAND, Ohio (August 3, 2022)—The legalization of medical cannabis has led to its use in treating a growing number of health problems. A new study suggests that it is becoming more common for women to use medical cannabis for menopause-related symptoms. Perimenopausal women, who report significantly worse menopause symptoms (particularly depression), represent the greatest percentage of users. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).

Hormone changes associated with menopause are responsible for causing a wide array of bothersome symptoms, including hot flashes, sleep disturbance, depressed mood, and anxiety. Although several treatment options, particularly hormone therapy, have proven effective in managing these symptoms, not all women are able or willing to use these options. This has led to the ongoing search for more nonhormone treatment options.

Several observational studies previously demonstrated that medical cannabis use is associated with various clinical benefits, including improvements on measures of anxiety, mood, sleep, and pain, as well as cognitive improvement after treatment. But no studies to date have examined the safety and efficacy of medical cannabis to alleviate menopause-related symptoms.

In this new study involving more than 250 perimenopausal and postmenopausal women who were recruited through advertising targeted to women interested in women’s health and cannabis or cannabinoids, researchers sought to assess cannabis use, including modes of use, and to compare usage patterns between perimenopausal and postmenopausal women. Results suggested that many women (86%) currently use cannabis as an adjunct treatment for menopause-related symptoms via a variety of different modes of use, with the most common being smoking (84.3%) and edibles (78.3%). The most frequently reported indications for medical cannabis use were menopause-related disturbances of sleep and mood/anxiety.

Compared with postmenopausal participants, perimenopausal participants reported significantly worse menopause-related symptomatology, including more anxiety and hot flashes. Perimenopausal women were also more likely to report a higher incidence of depression and anxiety, as well as increased use of medical cannabis to treat these symptoms. Additional research is necessary to confirm the effectiveness of cannabis for the treatment of various menopause symptoms.

Study results are published in the article “A survey of medical cannabis use during perimenopause and postmenopause.”

“This study suggests that medical cannabis use may be common in midlife women experiencing menopause-related symptoms. Given the lack of clinical trial data on the efficacy and safety of medical cannabis for management of menopause symptoms, more research is needed before this treatment can be recommended in clinical practice. Healthcare professionals should query their patients about the use of medical cannabis for menopause symptoms and provide evidence-based recommendations for symptom management,” says Dr. Stephanie Faubion, NAMS medical director.

For more information about menopause and healthy aging, visit www.menopause.org.

Founded in 1989, The North American Menopause Society (NAMS) is North America’s leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field—including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education—makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit www.menopause.org.

Gender affects driverless car performance

Peer-Reviewed Publication

NEWCASTLE UNIVERSITY

Newcastle University research has shown that women respond quicker and exhibit more stable takeover control than men in automated cars.

The study focussed on level 3 automated vehicles (L3 AVs), which allow drivers to be completely disengaged from driving and perform non-driving related activities. However, in L3 AVs human drivers’ intervention in the control of the vehicle may still be required in some situations, such as no signal or network connections, and places without complete road signage and markings.

The driving simulator study involved 76 drivers (33 females and 43 males), who were asked to take over control from L3 AVs in different weather conditions, with researchers measuring the timing and quality of takeover.

Published in the journal Nature Scientific Reportsthe results show that gender significantly affects takeover performance. Compared to men, women exhibited a smaller percentage of hasty takeovers and slightly faster reaction times as well as slightly more stable operation of the steering wheel.

Study Lead Author, Dr Shuo Li, of Newcastle University’s School of Engineering, said: “Our research strengthens the importance of tackling inequality in the context of future mobility. To create user-friendly automated vehicles, the manufacturers and designers need to adopt inclusive practices which fully consider the needs, requirements, performance, and preferences of end-users from different demographic groups.

“The next step, follow-up research is planned to explore gender differences in the needs and requirements associated with non-driving related tasks in Level 3 automated vehicles and investigate the effect of performing these tasks on end-users' behaviour and performance.”

Study Co-Author, Professor Phil Blythe, Professor of Intelligent Transport Systems at Newcastle University’s School of Engineering, added: “This research is part of a wider programme of work which is helping us understand the issue and challenges of designing automated vehicles in a way that end users will be able to understand and use safely.”

The findings of this paper have important implications for policymakers, the vehicle manufacturers  and academics for designing and facilitating user-friendly human–machine interactions in L3 AV.

The results also highlight that it is important for both genders to recognise they can use and interact with L3 AVs well, however more hands-on experience and teaching sessions could be provided to deepen their understanding of L3 Avs particularly at the point when the driver is required to retake manual control of the vehicle.

The researcher argue that design of the car interiors of L3 AVs should also take into account gender differences in the preferences of users for different non-driving related tasks, however the overriding requirement is to keep the required user interface and take-over tasks as simple as possible with a standard way of doing this irrespective of vehicle model.

Reference

Li, S., Blythe, P., Zhang, Y. et al. Analysing the effect of gender on the human–machine interaction in level 3 automated vehiclesSci Rep 12, 11645 (2022). https://doi.org/10.1038/s41598-022-16045-1

Having a partner more important than children to staving off loneliness during pandemic, new study finds

Peer-Reviewed Publication

UNIVERSITY OF RHODE ISLAND

KINGSTON, R.I. – August 3, 2022 – A new study released in the European Journal of Ageing found that having a partner had a greater impact than having children in helping to stave off loneliness among older adults during the pandemic’s first wave. Researchers at the University of Rhode Island, University of Florence, University of Maryland Baltimore County and the SGH Warsaw School of Economics analyzed data on more than 35,000 adults aged 50 and older from the Survey of Health, Ageing and Retirement in Europe to examine if unpartnered and childless older adults reported more loneliness and how that changed over the course of the pandemic.

Prior to the pandemic when asked “have you felt lonely recently?” those older adults who lacked one tie but had the other (unpartnered parents or partnered childless) were at greater risk for loneliness. However, during the pandemic, this combined status mattered less. More significant was the independent status of being either without a partner or childless. And specifically, not having a partner had the greatest bearing on loneliness.

During the pandemic’s first wave respondents were asked “have you felt lonely recently?” and “have you felt lonelier than before the pandemic?” While those without a partner and those without children were both more likely to experience loneliness, the unpartnered were more likely to undergo a more significant shift in their loneliness.

According to URI Assistant Professor of Health Studies Nekehia Quashie, one of the authors of the study, “What we found is that those without a partner had a higher risk of being lonely – even if they were not lonely prior to the pandemic. They had a higher risk of moving into loneliness – more so than those who had no children.”

Those who were lonely prior to the pandemic were less likely to exit loneliness, regardless of their status, said Quashie.

In the decade preceding the pandemic academics and public health officials have been increasingly concerned about loneliness, particularly among older adults, for a variety of reasons. With the advent of the COVID-19 pandemic and mitigation efforts centered squarely on measures like “physical distancing” and minimizing social interactions outside one’s immediate household, this heightened concern – especially for groups that were already at a greater risk for loneliness, said Quashie on the reason for the study.

Interestingly, “kinless” older adults (unpartnered and childless), while still at risk for loneliness, were not lonelier than the other two groups (unpartnered parents, partnered childless) prior to the pandemic. To researchers’ surprise, this held true over the course of the pandemic. 

“With those who are ‘kinless,’ it’s possible they have developed a range of resources and different coping strategies to manage a situation where they don’t have large networks to rely on – whether that is an immediate personal crisis or, as we saw in the pandemic, a major public health crisis,” said Quashie.

She added, “Remember that the concept of loneliness is very subjective – essentially we see loneliness arise when one’s desired or expected social interactions don’t match with their reality. So people have different thresholds for loneliness.”

While the study did not examine well-being outcomes such as anxiety and depression, the results highlight the increased risk for loneliness among certain groups – both prior to and during the pandemic. As the population of unpartnered and childless older adults grows globally it will be important for public health officials to take into account how measures intended to mitigate the spread of COVID-19, which limited social interaction, affected those groups already at higher risk for loneliness and consider approaches which limit social isolation.

Genes involved in heart disease are similar across all populations, VA study finds

Peer-Reviewed Publication

VETERANS AFFAIRS RESEARCH COMMUNICATIONS

The genes involved in coronary heart disease, the most common form of heart disease, appear to be nearly the same for everyone, according to a VA study.

Roughly one-third to one-half of everyone’s chances for developing this type of heart disease are rooted in their genes. This genetic risk seems to be the same across all major racial and ethnic backgrounds, including people of European, African, Japanese, and Indigenous ancestries, the VA study found. 

Some groups, such as African Americans, are more likely to suffer from heart disease, and our findings indicate that’s not because they have a higher genetic risk for the disease,” says study author Dr. Catherine Tcheandjieu, a genetic epidemiologist at the VA Palo Alto Health Care System and University of California San Francisco. “It confirms that other factors are responsible for more heart disease in those populations, such as access to health care and different lived experiences,” she adds.

The genetic study—the largest to date on heart disease—was published August 1, 2022, in Nature Medicine. It looked at nearly a quarter of a million cases of coronary heart disease, including more than 100,000 U.S. Veterans with the disease.

Coronary artery disease is the leading cause of death in the United States, responsible for one in every five deaths. It occurs when major blood vessels to the heart muscle become narrowed or blocked, which can lead to heart attack.

The study was led by investigators at the Palo Alto VA and involved researchers from several other VAs across the nation.

Research into the genetics of heart disease, like many other areas of health research, is mostly based on data from white people because of higher participation.

The Nature Medicine study, on the other hand, examined the genes of more than 27,000 Black and 12,000 Hispanic people with coronary artery disease. Most of these were Veterans, who agreed to share their genetic and health information for research as part of VAs Million Veteran Program, also known as MVP.

With data from MVP, VA researchers in this study confirmed for the first time that many genetic variations known to heighten heart disease risk in white people have the same effect in people of African and Hispanic ancestry. Additionally, researchers found nearly 100 new locations on the human genome where variations appear to increase risk of coronary artery disease.

To find these locations in the human genome that are linked to heart disease, researchers in the study carefully looked at the genes of nearly a quarter of a million people with heart disease and compared them to more than 840,000 people without the disease.

Ours is the first genetic study of coronary artery disease that had enough people of African and Hispanic descent to confirm previous findings in white people,” says corresponding author Dr. Themistocles (Tim) Assimes, a cardiologist and researcher at the VA Palo Alto Health Care System and Stanford University. This was directly because of VAs Million Veteran Program.”

Among nearly 900,000 Veterans in MVP, close to 150,000 are Black and more than 70,000 are Hispanic, making MVP one of the richest sources of data available for genetic research on all people, including those from diverse racial and ethnic backgrounds.

In 2007, researchers identified a gene termed the “heart attack gene” that can lead to up to a 50% lifetime chance of developing heart disease. For more than a decade, researchers have known this gene is linked to higher chances of early and more severe heart disease in white, South Asian, and East Asian populations. But genetic studies never had enough people of other ancestries to determine whether the same held true for other populations.

That is, until now.

As part of the Nature Medicine study, VA researchers were able to show that the region of DNA where this heart attack gene” sits appears to play much less of a role in altering the risk of disease among people with African ancestry, including a majority of African Americans and many Hispanics.

This is because the genetic miscoding, also known as a genetic variation, does not exist in people with African ancestry.

“It’s possible other ‘heart attack’ genes exist in Black populations,” Assimes adds, “but to find out, we need to do more research and make it a priority to invite many more people with African origins to participate in our genetic studies.”

Researchers from this study used their findings to create new genetic tests to better predict who might develop coronary heart disease in the future. These new tests are not much different than cholesterol, blood pressure, and diabetes tests, except they provide an idea of how high or low someone’s inherited risk of heart disease is from birth.

The impacts of this study on health care are happening now,” explains Tcheandjieu. She acknowledges, however, more fine-tuning needs to be done to fully capture genetic risk in Black people.

The best way to improve these genetic tests, also known as polygenic risk scores, is to study more people of African background such as African and Hispanic Americans, as well as people from Africa. This will allow us to discover all the miscodings in genes that increase risk for heart disease in diverse populations and make sure these tests capture that,” says Assimes.

An important next step is to see how well these new genetic tests accurately predict one’s risk for heart disease, say the researchers. The way to do that is through clinical trials, where researchers compare health outcomes for people who received genetic testing compared to people who didn’t.

For now, this study establishes a solid foundation for researchers to begin building the future of individualized heart health for everyone.